Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting

NCT07208305 is registered in ClinicalTrials.gov with Affiliated Hospital of Qinghai University as lead sponsor.

NCT NCT07208305
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07208305 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
Lead sponsor
Affiliated Hospital of Qinghai University
Phase
Phase 3
Overall status
Recruiting
Start date
February 3, 2026
Completion date
December 30, 2027
Enrollment
222 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nausea, vomiting